# ClinicalTrials.gov record NCT06727331

> PeptideScanner retained ClinicalTrials.gov record NCT06727331 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct06727331-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-09
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06727331-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06727331-tirzepatide-v1.json
- Content SHA-256: `fe6d6f8eae356d2687ce27fd764b33ffc91130a1ba67e3d657f01b02fc456b7a`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06727331 ([`ctg-observation-nct06727331-2026-07-09-09715248765b`](#source-ctg-observation-nct06727331-2026-07-09-09715248765b))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06727331 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06727331-2026-07-09-09715248765b`](#source-ctg-observation-nct06727331-2026-07-09-09715248765b))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06727331 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06727331-2026-07-09-09715248765b`](#source-ctg-observation-nct06727331-2026-07-09-09715248765b))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06727331-2026-07-09-09715248765b`](#source-ctg-observation-nct06727331-2026-07-09-09715248765b))

## Sources

<a id="source-ctg-observation-nct06727331-2026-07-09-09715248765b"></a>
- **ClinicalTrials.gov record NCT06727331 · retained source version 2026-07-09:09715248765b4e7d805f72f82c51c50ddaa39f2c2a6ad85fd1329b070d961df8** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06727331) (`ctg-observation-nct06727331-2026-07-09-09715248765b`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06727331." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06727331-tirzepatide-v1.json SHA-256: fe6d6f8eae356d2687ce27fd764b33ffc91130a1ba67e3d657f01b02fc456b7a.